1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Vera Yuan
Vera Yuan
Articles (1063) 

Mario Gabelli Comments on InterMune Inc

October 28, 2014 | About:

InterMune Inc. (ITMN) is a California based biotechnology company focused on the research, development, and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. On August 24, 2014, InterMune received a $74 cash per share tender offer from Swiss pharmaceuticals company Roche Holding AG, valuing the company at $8.3 billion. The offer was conditioned on tender acceptance of a majority of InterMune’s outstanding shares. The offer successfully concluded on September 29, 2014. The Fund earned a 13.2% return.

From Mario Gabelli (Trades, Portfolio)’s ABC Fund Q3 2014 Commentary.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by Vera Yuan

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)